Biocon quest for partner in China to test generic versions of Novo Nordisk Wegovy, Ozempic Ruchika Sharma21 Jun 2024 3:56 PM ISTShanghai: Biocon is looking for a partner in China to test generic versions of Novo Nordisk's weight loss treatment Wegovy and diabetes...
USFDA issues 3 observations for Biocon Visakhapatnam API facility Ruchika Sharma16 Jun 2024 11:00 AM ISTBangalore: Biocon has informed in a BSE filing that the U.S. Food and Drug Administration (USFDA) has concluded...
Biocon appoints Mukesh Kamath as Interim CFO, Key Managerial Personnel Ruchika Sharma13 Jun 2024 4:09 PM ISTBangalore: Biocon has announced the appointment of Mukesh Kamath, Head - Business Finance R&D, as the Interim Chief Financial Officer and Key...
Biocon gets USFDA nod for antifungal medication Micafungin Ruchika Sharma4 Jun 2024 2:51 PM ISTBengaluru: Biocon Limited has received approval from the U.S. Food and Drug Administration (US FDA), for its vertically integrated, complex...
Biocon, Handok ink pact for commercialization of chronic weight management Liraglutide in South Korea Ruchika Sharma24 May 2024 1:30 PM ISTBengaluru: A global biopharmaceutical company, Biocon Limited, has announced the signing of an exclusive licensing and supply agreement...
Biocon Biologics forays into US Ophthalmology market with USFDA nod for Yesafili Ruchika Sharma21 May 2024 11:30 AM ISTBengaluru: Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd, today announced that the U.S....
Biocon net profit declines 57 percent to Rs 136 crore in Q4 Ruchika Sharma20 May 2024 5:45 PM ISTNew Delhi: Biocon, a biotech company has recorded a 57 percent decrease in its consolidated net profit to Rs 136 crore for the fourth...
Biocon, Medix join hands for commercialization of weight management drug Liraglutide in Mexico Ruchika Sharma13 May 2024 12:01 PM ISTBengaluru: Biocon Limited, an innovation-led global biopharmaceutical company, today announced the signing of a semi-exclusive distribution and...
Biocon Limited signs an exclusive licensing and supply agreement for generic Ozempic (Semaglutide) commercialization in Brazil with Biomm S.A. Ruchika Sharma20 April 2024 10:13 AM ISTBiocon, Biomm S.A. ink pact for diabetes drug Semaglutide commercialization in Brazil
Biocon gets MHRA UK nod for weight management injection Liraglutide Ruchika Sharma1 April 2024 2:22 PM ISTBangalore: Biocon Limited, through its European partner, Zentiva, has received approval from the Medicines and Healthcare Products Regulatory...
Biocon obtains approval for diabetes drug Liraglutide in UK Ruchika Sharma28 March 2024 2:30 PM ISTBengaluru: Biocon Limited, a global biopharmaceuticals company, has announced that the Company has received approval from the Medicines and...
Eris Lifesciences acquires Biocon Biologics India branded formulation business for Rs 1242 crore Susmita Roy15 March 2024 1:51 PM ISTMumbai: Eris Lifesciences Ltd., a branded formulations company, has announced the acquisition of Biocon Biologics' India branded formulation...
